Anbio Biotechnology is a global medical technology company dedicated to decentralizing diagnostics and improving patient outcomes through rapid, accessible, and reliable testing solutions. The Company specializes in a comprehensive in vitro diagnostics (IVD) portfolio spanning multiple core technology platforms, including FIA, CLIA, RT-PCR, LFIA, LAMP, and Dry Chemistry. With a growing international presence across Europe, APAC, the Americas, and Africa, Anbio bridges the gap between centralized laboratories and immediate site-of-care testing by delivering affordable, clinically reliable results with rapid turnaround times. Its solutions are designed to support clinical laboratories, point-of-care settings, and at-home wellness applications worldwide.